Senores Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that the trading window for its securities will remain closed from October 1, 2025, until 48 hours after the announcement of unaudited financial results for the quarter and half year ending September 30, 2025. This is a routine compliance measure under SEBI's insider trading regulations and applies to directors, promoters, designated persons, and their immediate relatives. The board meeting date to approve the upcoming Q2/H1 FY26 results has not yet been disclosed and will be communicated separately. The intimation was signed by Company Secretary Vinay Kumar Mishra.
This is a standard regulatory disclosure with no material impact on the stock price. It simply means insiders cannot trade in the company's shares ahead of the September quarter earnings announcement, which is expected within the next few weeks.